stockportfolio.pro
Organon & Co. Revenue 2019–2025
Organon & Co. (OGN) annual revenue by fiscal year, computed from SEC filings. Compound growth -3.7%/yr over 6 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $6.22B | -2.9% |
| FY 2024 | $6.40B | +2.2% |
| FY 2023 | $6.26B | +1.4% |
| FY 2022 | $6.17B | -2.1% |
| FY 2021 | $6.30B | -3.5% |
| FY 2020 | $6.53B | -16.0% |
| FY 2019 | $7.78B | — |
Source: Organon & Co. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Organon & Co.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeOrganon & Co. — frequently asked questions
What is Organon & Co.'s revenue?
Organon & Co. (OGN) reported revenue of $6.22B for fiscal year 2025, per its SEC filings.
How has Organon & Co.'s revenue changed over time?
Between fiscal 2019 and 2025, OGN's revenue declined at roughly 3.7% per year (compound annual rate), from $7.78B to $6.22B.
Where does this data come from?
Figures are computed from Organon & Co.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.